| Molecular formula | C119H204N34O32S2 |
| Molecular weight | 2687.2 g/mol |
| Registered trials | 7 |
| PubChem CID | 16131438 |
What humanin is
Humanin is a peptide with no approved drug label and no FDA-cleared indication. It has not been evaluated by regulators for safety or effectiveness in any condition. Chemically, it is identified by PubChem CID 16131438, with a molecular formula of C119H204N34O32S2 and a molecular weight of about 2687.2.
Trial footprint
Seven registered clinical trials reference humanin. The available samples do not test humanin as an administered treatment but involve it as part of broader research contexts. One recruiting trial, "Analysis of Effects of High-intensity Physical Exercise in Subjects With Dialyzed Chronic Kidney Disease and in Conservative Treatment" (NCT07438002), is examining exercise effects in kidney disease patients. Another recruiting study, a muscle biopsy investigation in cerebral palsy (NCT05506228), and a third trial on IVF outcomes in polycystic ovary syndrome patients (NCT04104958, status unknown), also appear in the registry. These listings reflect registered research activity, not evidence of any therapeutic benefit.
FAQ
No. Humanin has no FDA-approved label, brand name, or indication. It remains an unapproved research compound.
Humanin appears in a small number of registered clinical trials, including studies on exercise in kidney disease, muscle biopsies in cerebral palsy, and IVF outcomes in polycystic ovary syndrome. These trials do not establish that humanin is effective for any condition.
There are 7 registered clinical trials referencing humanin as of the most recent data retrieval.
Humanin is a peptide with the molecular formula C119H204N34O32S2 and a molecular weight of approximately 2687.2. It is cataloged in PubChem under CID 16131438.
No adverse event report data is currently available for humanin, so no side effect pattern can be summarized at this time.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem ClinicalTrials.gov
Updated 2026-11-07